STEVEN M. PAUL - Director at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

STEVEN M. PAUL - trading volume in the past year for Rapport Therapeutics, Inc.

Holdings reported by STEVEN M. PAUL for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 41,666 $1,040,450 $24.97 12 Sep 2025 By Paul Capital Strategy III Fund LLC
Stock Option (Right to Buy) 21,850 17 Jun 2025 Direct Common Stock

Transactions reported by STEVEN M. PAUL for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.